|
⚲
|
| Keyboard |
| LaCascia Michael
✚
|
|
|---|---|
| CIK # | 0001831755 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001831755] | |
| 4 | [0001831755] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Foghorn Therapeutics Inc | |
| LaCascia Michael |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Foghorn Therapeutics Inc FHTX
Stock option (right to buy) · derivative
|
2026-01-30 | Grant | 295,000 | $5.71 | 1,684,450 |
|
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
|
2025-01-22 | Grant | 126,000 | $4.37 | 550,620 |
|
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
|
2024-01-24 | Grant | 100,000 | $3.06 | 306,000 |
|
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
|
2023-01-26 | Grant | 90,000 | $0.00 | |
|
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
|
2022-01-26 | Grant | 135,000 | $0.00 | |
|
Foghorn Therapeutics Inc FHTX
Stock Option (Right to Buy) · derivative
|
2020-11-17 | Grant | 162,162 | $0.00 |